Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: An analysis of ACS-NSQIP

Nutrition Journal

Volumn 14, Issue 1, 2015, Pages

  Hu, Wan H ^a,b,c   Cajas Monson, Luis C ^a   Eisenstein, Samuel ^a,b   Parry, Lisa ^a,b   Cosman, Bard ^a,d   Ramamoorthy, Sonia ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; SERUM ALBUMIN;

ABDOMINAL ABSCESS; ACUTE KIDNEY FAILURE; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CANCER SURGERY; CEREBROVASCULAR ACCIDENT; COLORECTAL CANCER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; HYPOALBUMINEMIA; KIDNEY FAILURE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALNUTRITION; MORBIDITY; NUTRITIONAL ASSESSMENT; PNEUMONIA; PREDICTION; PREOPERATIVE PERIOD; PREVALENCE; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SURGICAL INFECTION; SURGICAL MORTALITY; URINARY TRACT INFECTION; WEIGHT REDUCTION; WOUND DEHISCENCE; COLORECTAL NEOPLASMS; METABOLISM; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

BODY MASS INDEX; COLORECTAL NEOPLASMS; HUMANS; HYPOALBUMINEMIA; LENGTH OF STAY; LOGISTIC MODELS; MALNUTRITION; MORBIDITY; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 84941118169     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/s12937-015-0081-5     Document Type: Article

References (22)

1. Gupta D, Vashi PG, Lammersfeld CA, Braun DP. Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature. Ann Nutr Metab. 2011;59:96-106.
2. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.
3. Segura A, Pardo J, Jara C, Zugazabeitia L, Carulla J, de Las PR, et al. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. Clin Nutr. 2005;24:801-14.
4. Ramos Chaves M, Boleo-Tome C, Monteiro-Grillo I, Camilo M, Ravasco P. The diversity of nutritional status in cancer: new insights. Oncologist. 2010;15:523-30.
5. Zhang L, Lu Y, Fang Y. Nutritional status and related factors of patients with advanced gastrointestinal cancer. Br J Nutr. 2014;111:1239-44.
6. Huhmann MB, Cunningham RS. Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol. 2005;6:334-43.
7. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
8. Heys SD, Walker LG, Deehan DJ, Eremin OE. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb. 1998;43:163-8.
9. Lai CC, You JF, Yeh CY, Chen JS, Tang R, Wang JY, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011;26:473-81.
10. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15:2164-72.
11. Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R, et al. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013;119:1528-36.
12. Smith RK, Broach RB, Hedrick TL, Mahmoud NN, Paulson EC. Impact of BMI on postoperative outcomes in patients undergoing proctectomy for rectal cancer: a national surgical quality improvement program analysis. Dis Colon Rectum. 2014;57:687-93.
13. Abe Vicente M, Barao K, Silva TD, Forones NM. What are the most effective methods for assessment of nutritional status in outpatients with gastric and colorectal cancer? Nutr Hosp. 2013;28:585-91.
14. Yasunaga H, Horiguchi H, Matsuda S, Fushimi K, Hashimoto H, Ayanian JZ. Body mass index and outcomes following gastrointestinal cancer surgery in Japan. Br J Surg. 2013;100:1335-43.
15. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009;250:177-86.
16. Vollmer Jr CM, Lewis RS, Hall BL, Allendorf JD, Beane JD, Behrman SW, et al. Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index. Ann Surg. 2015;261:527-36.
17. Elahi MM, McMillan DC, McArdle CS, Angerson WJ, Sattar N. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer. 2004;48:171-3.
18. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246:1047-51.
19. Lohsiriwat V, Lohsiriwat D, Boonnuch W, Chinswangwatanakul V, Akaraviputh T, Lert-Akayamanee N. Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgery. World J Gastroenterol. 2008;14:1248-51.
20. Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, et al. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009;9:288.
21. Chin CC, Kuo YH, Yeh CY, Chen JS, Tang R, Changchien CR, et al. Role of body mass index in colon cancer patients in Taiwan. World J Gastroenterol. 2012;18:4191-8.
22. Ishizuka M, Nagata H, Takagi K, Kubota K. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg. 2009;250:268-72.